Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)

Nefrologia. 2011:31 Suppl 1:3-32. doi: 10.3265/Nefrologia.pre2011.Jan.10816.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Algorithms
  • Biomarkers
  • Bone Density Conservation Agents / therapeutic use
  • Bone Diseases, Metabolic / diagnosis
  • Bone Diseases, Metabolic / diet therapy
  • Bone Diseases, Metabolic / drug therapy
  • Bone Diseases, Metabolic / etiology
  • Bone Diseases, Metabolic / physiopathology
  • Bone Diseases, Metabolic / prevention & control*
  • Bone Remodeling
  • Calcinosis / etiology
  • Calciphylaxis / etiology
  • Calciphylaxis / prevention & control
  • Calcium / metabolism
  • Calcium / therapeutic use
  • Chelation Therapy
  • Chronic Disease
  • Combined Modality Therapy
  • Diagnostic Imaging
  • Humans
  • Hyperparathyroidism, Secondary / etiology
  • Hyperparathyroidism, Secondary / metabolism
  • Hyperparathyroidism, Secondary / surgery
  • Kidney Diseases / complications
  • Kidney Diseases / metabolism*
  • Kidney Diseases / therapy
  • Kidney Transplantation
  • Minerals / administration & dosage
  • Minerals / metabolism*
  • Parathyroid Hormone / metabolism
  • Parathyroidectomy
  • Phosphorus / metabolism
  • Receptors, Cell Surface / metabolism
  • Reference Values
  • Renal Dialysis
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / surgery
  • Renal Insufficiency, Chronic / therapy
  • Vitamin D / metabolism
  • Vitamin D / therapeutic use

Substances

  • Biomarkers
  • Bone Density Conservation Agents
  • Minerals
  • Parathyroid Hormone
  • Receptors, Cell Surface
  • Vitamin D
  • Phosphorus
  • Calcium